<DOC>
	<DOCNO>NCT02560181</DOCNO>
	<brief_summary>Radiation therapy consider standard treatment option management localized prostate cancer . Among 20-30 % patient recur , consensus optimal salvage therapy . Salvage option available isolated local recurrence include ; temporary permanent implantation radioactive seed prostate , complete removal prostate gland , use low temperature treat disease ( cryotherapy ) , high frequency ultrasound treat disease . There risks complication associate treatment , presently consensus treatment best . The aim pilot study look feasibility toxicity whole gland salvage treatment prostate use temporary implantation radioactive seed prostate .</brief_summary>
	<brief_title>Pilot Study Whole Gland Salvage HDR Prostate Brachytherapy Locally Recurrent Prostate Cancer</brief_title>
	<detailed_description>Radiation therapy consider standard treatment option management localized prostate cancer . Among 20-30 % patient recur , consensus optimal salvage therapy . Salvage option available isolated local recurrence include ; temporary permanent implantation radioactive seed prostate , complete removal prostate gland , use low temperature treat disease ( cryotherapy ) , high frequency ultrasound treat disease . There risks complication associate treatment , presently consensus treatment best . The aim pilot study look feasibility toxicity whole gland salvage treatment prostate use temporary implantation radioactive seed prostate.Reports efficacy toxicity whole gland salvage HDR brachytherapy local recurrence external beam radiation therapy limit single-institution study small sample size . Given institution high volume prostate brachytherapy case Ontario receive significant number referral cancer centre brachytherapy , study aim add literature help guide salvage therapy practice within institution .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>biopsy confirm locally recurrent prostate adenocarcinoma &gt; 30mths completion XRT stereotactic transperineal biopsy Staging T2 weight , DWI DCE MRI demonstrate recurrence confine prostate , correlate stereotactic transperineal biopsy Staging CT MRI ( abdomen pelvis ) bone scan negative metastasis IPSS &lt; 15 Baseline ( post XRT ) serum PSA &lt; 10ng/mL Prostate volume measure TRUS &lt; 50cc ECOG performance status 01 prior XRT prostate exceed 78 Gy ( 2Gy fraction ) disease adjacent urethra visible MRI follow prior therapy ; TURP , radionuclide prostate brachytherapy , prostatectomy prostatic cryosurgery , HIFU , bilateral orchiectomy , chemotherapy prostatic carcinoma evidence castrate resistance ( define PSA &gt; 3ng/mL testosterone &lt; 1.7nmol/L ) Patients could combine androgen blockade initial XRT exclude start due PSA progression</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>recurrent prostate cancer , HDR whole gland salvage</keyword>
</DOC>